217 related articles for article (PubMed ID: 15713962)
1. Detection of hypermethylated genes in women with and without cervical neoplasia.
Feng Q; Balasubramanian A; Hawes SE; Toure P; Sow PS; Dem A; Dembele B; Critchlow CW; Xi L; Lu H; McIntosh MW; Young AM; Kiviat NB
J Natl Cancer Inst; 2005 Feb; 97(4):273-82. PubMed ID: 15713962
[TBL] [Abstract][Full Text] [Related]
2. Promoter hypermethylation of tumor suppressor genes in urine from patients with cervical neoplasia.
Feng Q; Hawes SE; Stern JE; Dem A; Sow PS; Dembele B; Toure P; Sova P; Laird PW; Kiviat NB
Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1178-84. PubMed ID: 17548682
[TBL] [Abstract][Full Text] [Related]
3. Promoter hypermethylation of CDH13, DAPK1 and TWIST1 genes in precancerous and cancerous lesions of the uterine cervix.
Missaoui N; Hmissa S; Trabelsi A; Traoré C; Mokni M; Dante R; Frappart L
Pathol Res Pract; 2011 Jan; 207(1):37-42. PubMed ID: 21129853
[TBL] [Abstract][Full Text] [Related]
4. Methylation of the hsa-miR-124, SOX1, TERT, and LMX1A genes as biomarkers for precursor lesions in cervical cancer.
Rogeri CD; Silveira HCS; Causin RL; Villa LL; Stein MD; de Carvalho AC; Arantes LMRB; Scapulatempo-Neto C; Possati-Resende JC; Antoniazzi M; Longatto-Filho A; Fregnani JHTG
Gynecol Oncol; 2018 Sep; 150(3):545-551. PubMed ID: 29960712
[TBL] [Abstract][Full Text] [Related]
5. TSLC1 gene silencing in cervical cancer cell lines and cervical neoplasia.
Steenbergen RD; Kramer D; Braakhuis BJ; Stern PL; Verheijen RH; Meijer CJ; Snijders PJ
J Natl Cancer Inst; 2004 Feb; 96(4):294-305. PubMed ID: 14970278
[TBL] [Abstract][Full Text] [Related]
6. [Promoter methylation of DAPK1, RAR-β and MGMT in exfoliated cervical cytology and its clinical application].
Zhong ZJ; Yang JX; Cao DY; Sun Y; Sun LL; Cheng XM; Chen J; Lang JH; Shen K
Zhonghua Fu Chan Ke Za Zhi; 2012 Mar; 47(3):196-200. PubMed ID: 22781071
[TBL] [Abstract][Full Text] [Related]
7. Associations between methylation of paternally expressed gene 3 (PEG3), cervical intraepithelial neoplasia and invasive cervical cancer.
Nye MD; Hoyo C; Huang Z; Vidal AC; Wang F; Overcash F; Smith JS; Vasquez B; Hernandez B; Swai B; Oneko O; Mlay P; Obure J; Gammon MD; Bartlett JA; Murphy SK
PLoS One; 2013; 8(2):e56325. PubMed ID: 23418553
[TBL] [Abstract][Full Text] [Related]
8. Aberrant promoter methylation can be useful as a marker of recurrent disease in patients with cervical intraepithelial neoplasia grade III.
Terra AP; Murta EF; Maluf PJ; Caballero OL; Brait M; Adad SJ
Tumori; 2007; 93(6):572-9. PubMed ID: 18338492
[TBL] [Abstract][Full Text] [Related]
9. DAPK1, MGMT and RARB promoter methylation as biomarkers for high-grade cervical lesions.
Sun Y; Li S; Shen K; Ye S; Cao D; Yang J
Int J Clin Exp Pathol; 2015; 8(11):14939-45. PubMed ID: 26823825
[TBL] [Abstract][Full Text] [Related]
10. Predicting cervical intraepithelial neoplasia recurrence in HIV-infected and -noninfected women by detecting aberrant promoter methylation in the CDH1, TIMP3, and MGMT genes.
Teixeira da Costa Lodi C; Michelin MA; Miranda Lima MI; Murta EFC; Braga LDC; Montes L; Melo VH
Arch Gynecol Obstet; 2018 Nov; 298(5):971-979. PubMed ID: 30218185
[TBL] [Abstract][Full Text] [Related]
11. Cytology versus HPV testing for cervical cancer screening in the general population.
Koliopoulos G; Nyaga VN; Santesso N; Bryant A; Martin-Hirsch PP; Mustafa RA; Schünemann H; Paraskevaidis E; Arbyn M
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD008587. PubMed ID: 28796882
[TBL] [Abstract][Full Text] [Related]
12. Detection of hypermethylated genes as markers for cervical screening in women living with HIV.
Kremer WW; Van Zummeren M; Novianti PW; Richter KL; Verlaat W; Snijders PJ; Heideman DA; Steenbergen RD; Dreyer G; Meijer CJ
J Int AIDS Soc; 2018 Aug; 21(8):e25165. PubMed ID: 30101434
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide methylation profiling identifies hypermethylated biomarkers in high-grade cervical intraepithelial neoplasia.
Lendvai Á; Johannes F; Grimm C; Eijsink JJ; Wardenaar R; Volders HH; Klip HG; Hollema H; Jansen RC; Schuuring E; Wisman GB; van der Zee AG
Epigenetics; 2012 Nov; 7(11):1268-78. PubMed ID: 23018867
[TBL] [Abstract][Full Text] [Related]
14. Discovery of new methylation markers to improve screening for cervical intraepithelial neoplasia grade 2/3.
Boers A; Wang R; van Leeuwen RW; Klip HG; de Bock GH; Hollema H; van Criekinge W; de Meyer T; Denil S; van der Zee AGJ; Schuuring E; Wisman GBA
Clin Epigenetics; 2016; 8():29. PubMed ID: 26962367
[TBL] [Abstract][Full Text] [Related]
15. Methylation of p16INK4a is a non-rare event in cervical intraepithelial neoplasia.
Kang S; Kim J; Kim HB; Shim JW; Nam E; Kim SH; Ahn HJ; Choi YP; Ding B; Song K; Cho NH
Diagn Mol Pathol; 2006 Jun; 15(2):74-82. PubMed ID: 16778587
[TBL] [Abstract][Full Text] [Related]
16. Concordance analysis of methylation biomarkers detection in self-collected and physician-collected samples in cervical neoplasm.
Chang CC; Huang RL; Liao YP; Su PH; Hsu YW; Wang HC; Tien CY; Yu MH; Lin YW; Lai HC
BMC Cancer; 2015 May; 15():418. PubMed ID: 25985991
[TBL] [Abstract][Full Text] [Related]
17. Amplification of the 3q chromosomal region as a specific marker in cervical cancer.
Wright TC; Compagno J; Romano P; Grazioli V; Verma Y; Kershnar E; Tafas T; Kilpatrick MW
Am J Obstet Gynecol; 2015 Jul; 213(1):51.e1-51.e8. PubMed ID: 25659466
[TBL] [Abstract][Full Text] [Related]
18. The hypermethylation and protein expression of p16 INK4A and DNA repair gene O6-methylguanine-DNA methyltransferase in various uterine cervical lesions.
Lin Z; Gao M; Zhang X; Kim YS; Lee ES; Kim HK; Kim I
J Cancer Res Clin Oncol; 2005 Jun; 131(6):364-70. PubMed ID: 15785933
[TBL] [Abstract][Full Text] [Related]
19. P16 methylation is an early event in cervical carcinogenesis.
Huang LW; Pan HS; Lin YH; Seow KM; Chen HJ; Hwang JL
Int J Gynecol Cancer; 2011 Apr; 21(3):452-6. PubMed ID: 21436693
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of candidate methylation markers to detect cervical neoplasia.
Shivapurkar N; Sherman ME; Stastny V; Echebiri C; Rader JS; Nayar R; Bonfiglio TA; Gazdar AF; Wang SS
Gynecol Oncol; 2007 Dec; 107(3):549-53. PubMed ID: 17894941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
